Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robert H. Bergstrand"'
Autor:
Jan Aberg, Harry J.G.M. Crijns, Kong I. Lie, Olle Almgren, Tom J.M. Tobé, Jaap Haaksma, Ans C.P. Wiesfeld, Robert H. Bergstrand
Publikováno v:
American Journal of Cardiology, 70(11), 990-996. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
The electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, were investigated in a randomized, placebo-controlled, double-blind study, and efficacy was evaluated. Ten post-myocardial infarction patients with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2137e040546c9dfb7483dd552c817d36
https://doi.org/10.1016/0002-9149(92)90349-4
https://doi.org/10.1016/0002-9149(92)90349-4
Autor:
Wade W Sutton, Robert H Bergstrand, Raymond L. Woosley, H T Wolfenden, Ted Wang, G. R. Avant, Dan M. Roden, Grant R. Wilkinson, Lyle A. Siddoway, Alastair J. J. Wood
Publikováno v:
Clinical Pharmacology and Therapeutics. 40:148-154
The antiarrhythmic agent encainide undergoes extensive first-pass hepatic metabolism after oral dosing. The active metabolites O-desmethylencainide and 3-methoxy-O-desmethylencainide are formed in subjects who are extensive metabolizers (EMs), a phen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db34bcae12592a05e970c216558c717d
https://doi.org/10.1038/clpt.1986.155
https://doi.org/10.1038/clpt.1986.155
Autor:
Raymond L. Woosley, William J. Stone, H T Wolfenden, Ted Wang, Alastair J. J. Wood, Robert H Bergstrand, Dan M. Roden, Grant R. Wilkinson
Publikováno v:
Clinical pharmacology and therapeutics. 40(1)
The antiarrhythmic agent encainide undergoes extensive presystemic biotransformation to form O-desmethylencainide (ODE) and 3-methoxy-ODE (MODE) in subjects who exhibit the extensive metabolizer (EM) phenotype for debrisoquin 4-hydroxylation. These m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5fc2730135a9d78371f92fafc7d6fa
https://pubmed.ncbi.nlm.nih.gov/3087679
https://pubmed.ncbi.nlm.nih.gov/3087679
Autor:
Gordon J. Conard, Robert H Bergstrand, Lyle A. Siddoway, Ted Wang, Katherine A. Thompson, Don Kvam, Dan M. Roden, Raymond L. Woosley
Publikováno v:
Clinical pharmacology and therapeutics. 43(5)
A two-part pharmacokinetic approach was used to prospectively develop and test intravenous flecainide infusion regimens for the acute therapy for ventricular arrhythmias. Initially, each of nine known responders to oral flecainide was given a rapid f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a54e67c3a4446c01270b65515a2e4f2
https://pubmed.ncbi.nlm.nih.gov/3130211
https://pubmed.ncbi.nlm.nih.gov/3130211
Autor:
Ted Wang, Katherine A. Thompson, Dan M. Roden, Robert H Bergstrand, Lyle A. Siddoway, Henry J. Duff, Raymond L. Woosley
Publikováno v:
The American journal of cardiology. 57(13)
Sotalol is a nonselective β-receptor antagonist that prolongs action potential duration and refractoriness in vitro at higher concentrations than those associated with heart rate slowing. To determine if this additional action can be expressed in hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e08c11d9c10bf5e44d85adaa766607
https://pubmed.ncbi.nlm.nih.gov/3706170
https://pubmed.ncbi.nlm.nih.gov/3706170